Organization Profile

You just read:

Aeterna Zentaris Granted Special Protocol Assessment by the FDA for Phase 3 Registration Trial in Endometrial Cancer with AEZS-108

News provided by

AETERNA ZENTARIS INC.

Dec 28, 2012, 07:30 ET